MedPath

Antibiotic therapy for premature rupture of membranes and maternal outcomes in sayyad shirazi hospital-Gorga

Phase 2
Conditions
Premature rupture of membranes.
Premature rupture of membranes
Registration Number
IRCT2017060228381N1
Lead Sponsor
*Golestan University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
Female
Target Recruitment
140
Inclusion Criteria

Conditions of entry:
Pregnant women with complaints of irritation between 34-24 weeks of pregnancy after ensuring rupture of membranes-by examination and testing Nitrazine;
Exclusion criteria:Positive rectovaginal culture.
Sample size: 140; divided into two groups of 70 pregnant woman.

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Gestational age. Timepoint: admition date with PPROM. Method of measurement: According to the first FHR sonography.
Secondary Outcome Measures
NameTimeMethod
Gestational age. Timepoint: delivery time. Method of measurement: According to the first FHR sonography.
© Copyright 2025. All Rights Reserved by MedPath